Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 2 minute read Pharma Industry News Kymera Therapeutics advances Phase 2 trials of KT-474 in partnership with Sanofi Kymera Therapeutics, Inc. (NASDAQ: KYMR), a leader in the biopharmaceutical sector focusing on targeted protein degradation (TPD), has… byPallavi MadhirajuJuly 9, 2024